Home > Resources > Whitepapers > Biotech reinvented

Biotech reinvented

March 20, 2019

The biotechnology industry (Biotech) is now about 30 years old – a long enough time in which to evaluate how it’s done. Unfortunately, despite some notable successes, it hasn’t completely fulfilled its promise. The business model on which Biotech has historically relied is also breaking down, as the research base moves east and raising funds gets harder. And the distinctions between Biotech and the pharmaceutical industry (Pharma) are disappearing, with the convergence of the two sectors. But Biotech can’t turn to Pharma for guidance because Pharma’s business model has other flaws – as we explained in “Pharma 2020: Challenging business models”, the White Paper we published in April 2009.1 So what should Biotech do? We believe it should capitalise on the opportunities emerging in the healthcare arena – and reinvent itself by adopting a more collaborative approach.

Spotlight

Green Biologics Ltd.

Green Biologics Ltd. is a renewable chemicals company focussed on developing and delivering new green alternatives for everyday products. Our core products are renewable n-butanol and acetone.Our technology platform is built on biology and chemistry with core expertise in Clostridium microbial fermentation. We are using our novel technology platform to develop a robust product pipeline, extending the range of green chemicals and applying downstream synthetic chemistry to generate chemical derivatives used in a wide variety of everyday products (paints, coatings, inks, adhesives, textiles, cosmetics, food ingredients, household and industrial cleaners, shampoos and personal care products, fragrances, synthetic rubber, and a myriad of other end uses).

OTHER WHITEPAPERS

Early engagement and regulatory considerationsfor biotech

whitePaper | May 10, 2022

Biotechnology companies are at the epicenter of innovative drug development, with discoveries spanning from small molecules, large molecules, and biologics to genomic medicines

Multi-Attribute Methods for Biopharmaceutical Analysis

whitePaper | December 5, 2022

The adoption of LC-MS-based multi-attribute method (MAM) analysis for routine monitoring of biotherapeutic variation has progressed greatly over the last five years.

A digital ecosystem for Clinical Trails

whitePaper | July 30, 2021

Clinical trials are complex, lengthy, and resource-inefficient. The clinical research industry is responsible for the delivery of medical solutions to society by systematically evaluating their safety and efficacy in humans during so-called clinical trials. As exemplified by the COVID-19 pandemic, a steady and efficient influx of vaccines, therapeutics, and other innovative medical solutions is critical for meeting society’s current and future medical needs. Unfortunately, the industry faces several persistent issues that make clinical trial operations overly complex, lengthy, and resource-inefficient.

bFGF Supports Human ES Cell Self-Renewal

whitePaper | March 24, 2023

Basic fibroblast growth factor (bFGF) is an important cytokine used to support the growth and self renewal of human embryonic stem cells.

A Review of RNA Analysis using the Agilent AutomatedElectrophoresis Portfolio

whitePaper | July 15, 2022

Good-quality RNA is crucial to the success of many downstream applications, including qPCR, microarray analysis, and RNA sequencing. Agilent automated

Advanced Biopharmaceutical Manufacturing: An Evolution Underway

whitePaper | June 5, 2022

The past decade has seen a significant shift in the nature of the products being manufactured and sold by the innovative biopharmaceutical (biopharma) industry. The global biopharmaceutical portfolio of today reflects increased therapeutic competition, a greater prevalence of large molecule drugs, expansion in the number of personalized or targeted products, and a rise of treatments for many orphan diseases.

Spotlight

Green Biologics Ltd.

Events

8th International Conference on Bio-Sensing Technology

Conference

8th International Conference on Bio-Sensing Technology

Conference